SETD2 and acute leukemia: In past decades, the study of H3K36me3 and SETD2 mainly focus on their function as tumor suppressors, including clear cell renal cell carcinoma, chondroblastomas, lymphoma, acute leukemia, intestinal tumorigenesis, and so on [19,39–42].